Registration
TODD STRATEGY GROUP for CRISPR THERAPEUTICS, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reimbursements for cell and gene therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL EDATTEL New | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg |
| DANIEL M TODD New | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | Switzerland | Switzerland | 100.0% | $100,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| CRISPR THERAPEUTICS AG | 6300 Zug, CH |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.